Showing results (111-120 of 143) with videos related to

Sort By:
Pageof 15
Disease Models & Mechanisms|November 17, 2019
A novel patient-derived orthotopic xenograft model of esophageal adenocarcinoma provides a platform for translational discoveriesOmkara Lakshmi Veeranki, Zhimin Tong, Alicia Mejia, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2025
Activating <i>RET</i> Mutations Promotes Osteoblastic Bone Metastases in Medullary Thyroid CancerRozita Bagheri-Yarmand, Gabriel M Pagnotti, Joseph L Kidd, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 22, 2020
Optimizing the Conditioning Regimen for Hematopoietic Cell Transplant in Myelofibrosis: Long-Term Results of a Prospective Phase II Clinical TrialUday Popat, Rohtesh S Mehta, Roland Bassett, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 3, 2020
Clinico-pathologic characteristics and outcomes of the World Health Organization (WHO) provisional entity de novo acute myeloid leukemia with mutated RUNX1Andrés E Quesada, Guillermo Montalban-Bravo, Rajyalakshmi Luthra, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 31, 2012
High-dose infusional gemcitabine combined with busulfan and melphalan with autologous stem-cell transplantation in patients with refractory lymphoid malignanciesYago Nieto, Peter Thall, Ben Valdez, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 23, 2013
Chemical castration of melanoma patients does not increase the frequency of tumor-specific CD4 and CD8 T cells after peptide vaccinationLuis M Vence, Chiyu Wang, Himabindu Pappu, et al.
Bone Marrow Transplantation|January 5, 2021
Randomized phase II trial of extracorporeal phototherapy and steroids vs. steroids alone for newly diagnosed acute GVHDRohtesh S Mehta, Roland Bassett, Gabriela Rondon, et al.
Oncoimmunology|August 15, 2025
Lymphodepletion, tumor-infiltrating lymphocytes, and high versus low dose IL-2 followed by pembrolizumab in patients with metastatic melanomaMerve Hasanov, Simin Kiany, Marie-Andrée Forget, et al.
Transplantation and Cellular Therapy|May 26, 2022
Vorinostat Combined with Busulfan, Fludarabine, and Clofarabine Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Leukemia: Long-Term Study OutcomesGheath Alatrash, Chantal Saberian, Roland Bassett, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 7, 2016
Clofarabine Plus Busulfan is an Effective Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia: Long-Term Study ResultsPartow Kebriaei, Roland Bassett, Genevieve Lyons, et al.
Pageof 15